Literature DB >> 18968738

Speciation of arsenic in body fluids.

Kazuo T Suzuki1, Badal K Mandal, Yasumitsu Ogra.   

Abstract

Inorganic arsenic is metabolized by consecutive reduction and methylation reactions to dimethylated arsenic (DMA), and then excreted into the urine mostly in the form of DMA. Therefore, arsenic metabolites in the body fluids and organs/tissues are present in the form of inorganic (arsenite and arsenate) and methylated arsenics (MMA and DMA). Although pentavalent arsenics can be present mostly in the form of free ions, trivalent ones may be present more in the forms conjugated with thiol groups of glutathione (GSH) or proteins. Arsenic in the body fluids (plasma, bile and urine) is present in the soluble forms and can be speciated on ion exchange columns by HPLC with on-line detection by an inductively coupled argon plasma-mass spectrometer (ICP-MS). Free forms of arsenite, arsenate, and monomethylarsonous, monomethylarsonic, dimethylarsinous and dimethylarsinic acids in the body fluids have been demonstrated to be speciated simultaneously within 10 min or so on both anion and cation exchange columns together with arsenobetaine (AsB) and arsenocholine (AsC). Trivalent arsenics conjugated with GSH were eluted in intact forms on an anion exchange column but were liberated into free forms on a cation exchange column. Thus, free and GSH-conjugated arsenic metabolites in the bile and urine have been speciated simultaneously on ion exchange columns by HPLC-ICP-MS.

Entities:  

Year:  2002        PMID: 18968738     DOI: 10.1016/s0039-9140(02)00260-6

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  8 in total

1.  Environmental arsenic exposure and serum matrix metalloproteinase-9.

Authors:  Jefferey L Burgess; Margaret Kurzius-Spencer; Mary Kay O'Rourke; Sally R Littau; Jason Roberge; Maria Mercedes Meza-Montenegro; Luis Enrique Gutiérrez-Millán; Robin B Harris
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-12-12       Impact factor: 5.563

2.  Direct analysis of methylated trivalent arsenicals in mouse liver by hydride generation-cryotrapping-atomic absorption spectrometry.

Authors:  Jenna M Currier; Milan Svoboda; Diogo P de Moraes; Tomás Matousek; Jirí Dĕdina; Miroslav Stýblo
Journal:  Chem Res Toxicol       Date:  2011-03-11       Impact factor: 3.739

Review 3.  Arsenic: a Culpable Element and a Possible Menace for HIV/AIDS Patients.

Authors:  Akanksha Singh; P Ramalingam; Sameer Dhingra; V Ravichandiran; Krishna Murti
Journal:  Biol Trace Elem Res       Date:  2022-02-07       Impact factor: 4.081

4.  Speciation, formation, stability and analytical challenges of human arsenic metabolites.

Authors:  Lucy Yehiayan; Mahesh Pattabiraman; Konstantinos Kavallieratos; Xiaotang Wang; Lawrence H Boise; Yong Cai
Journal:  J Anal At Spectrom       Date:  2009-07-21       Impact factor: 4.023

5.  Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer).

Authors:  Araceli Hernández-Zavala; Tomáš Matoušek; Zuzana Drobná; David S Paul; Felecia Walton; Blakely M Adair; Dědina Jiří; David J Thomas; Miroslav Stýblo
Journal:  J Anal At Spectrom       Date:  2008       Impact factor: 4.023

6.  Comparative oxidation state specific analysis of arsenic species by high-performance liquid chromatography-inductively coupled plasma-mass spectrometry and hydride generation-cryotrapping-atomic absorption spectrometry.

Authors:  Jenna Currier; R Jesse Saunders; Lan Ding; Wanda Bodnar; Peter Cable; Tomáš Matoušek; John T Creed; Miroslav Stýblo
Journal:  J Anal At Spectrom       Date:  2013-06-01       Impact factor: 4.023

7.  Study on the Absorption of Arsenic Species in Realgar Based on the Form and Valence.

Authors:  Mingyi Sun; Yaolei Li; Ying Wang; Huimin Wu; Jing Liu; Longtai You; HuLinyue Peng; Huating Huang; Hongyu Jin; Xiaoxu Dong; Changhai Qu; Xingbin Yin; Jian Ni
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-23       Impact factor: 2.650

Review 8.  Realgar (α-As4S4) Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation.

Authors:  Miao Zhang; Jia-Yi Zhang; Ming-Qian Sun; Peng Lu; Jian-Xun Liu
Journal:  Chin J Integr Med       Date:  2020-05-16       Impact factor: 1.978

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.